Capstan Therapeutics, Inc. raised $175M in a Series B financing led by RA Capital Management to advance in vivo reprogramming of cells through RNA delivery using targeted lipid nanoparticles
Amount Raised
$175 Million
Round Type
Series B
San DiegoBiotechnologyHealth CareTherapeuticsInvestors
Description
Capstan Therapeutics, Inc. announced the successful closing of a $175M oversubscribed Series B financing. The financing was led by RA Capital Management, with participation from new investors Forbion, Johnson & Johnson Innovation - JJDC, Mubadala Capital, Perceptive Advisors, and Sofinnova Investments, as well as existing investors Alexandria Venture Investments, Bristol Myers Squibb, Eli Lilly and Company, Leaps by Bayer, Novartis Venture Fund, OrbiMed, Pfizer Ventures, Polaris Partners, and Vida Ventures.
Quick answer
Capstan Therapeutics raised $175 Million in a Series B round, dated March 20, 2024. Investors: Johnson & Johnson Innovation – JJDC, Vida Ventures, Polaris Partners, Pfizer Ventures, Orbi Med, Novartis Venture Fund, Leaps By Bayer and Eli Lilly And Company. Capstan Therapeutics is based in San Diego, California, United States.
- How much did Capstan Therapeutics raise?
- Capstan Therapeutics raised $175 Million in a Series B round on March 20, 2024.
- Who invested in Capstan Therapeutics?
- Johnson & Johnson Innovation – JJDC, Vida Ventures, Polaris Partners, Pfizer Ventures, Orbi Med, Novartis Venture Fund, Leaps By Bayer and Eli Lilly And Company are named as investors in this round.
- What does Capstan Therapeutics do?
- Capstan is a biotechnology company with a mission to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies.
- Where is Capstan Therapeutics based and how big is it?
- Capstan Therapeutics is based in San Diego, California, United States.
- Who are the decision-makers at Capstan Therapeutics?
- Fundz holds 1 contact at Capstan Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Capstan Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Zenas BioPharma raised $200M on May 3, 2024.
- BridgeBio raised $200M (Pre-Seed) on May 3, 2024.
- Delphia Therapeutics raised $67M (Series A) on May 2, 2024.
- Novocure raised $400M (Debt Financing) on May 2, 2024.
- Scipher Medicine raised $25M on May 2, 2024.
- Medicenna raised $15M on April 30, 2024.
Who to call at Capstan Therapeutics, and when
A new round usually means Capstan Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Capstan Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Capstan Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Capstan Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Capstan Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCapstan Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.